9 patents
Utility
Focal Treatment of Prostate Cancer
13 Oct 22
The embodiments include methods of treating prostate cancer by administering to a low grade unifocal prostate cancer tumor a composition comprising a therapeutically effective amount of pharmaceutically active ingredient capable of inducing necrosis of a low grade unifocal prostate cancer tumor, wherein administration reduces cancer incidence, cancer grade, and cancer progression (worsening) in the entire hemi-prostate where the initial focus was located and treated.
Paul Averback
Filed: 10 May 22
Utility
Method of Enhancing the Therapeutic Efficacy of Fexapotide Triflutate In Treating Luts
21 Jul 22
Disclosed are methods of enhancing the therapeutic efficacy of Fexapotide Triflutate (TF) in treating LUTS, both irritative and obstructive, that include administering a composition comprising FT at least twice over a period spanning more than one year.
Paul AVERBACK
Filed: 21 Dec 21
Utility
Focal Treatment of Prostate Cancer
4 Feb 21
The embodiments include methods of treating prostate cancer by administering to a low grade unifocal prostate cancer tumor a composition comprising a therapeutically effective amount of pharmaceutically active ingredient capable of inducing necrosis of a low grade unifocal prostate cancer tumor, wherein administration reduces cancer incidence, cancer grade, and cancer progression (worsening) in the entire hemi-prostate where the initial focus was located and treated.
Paul AVERBACK
Filed: 31 Jul 19
Utility
Methods of Treating Multifocal Cancer
4 Feb 21
The embodiments include methods of treating (preventing or reducing the incidence of) multifocal cancer by administering to a unifocal cancer focus a composition comprising a therapeutically effective amount of a therapeutically effective amount of pharmaceutically active ingredient capable of inducing necrosis of the unifocal cancer tumor, wherein administration reduces multifocal cancer incidence, multifocal cancer grade, and multifocal cancer progression (worsening) in the entire organ or organism.
Paul AVERBACK
Filed: 31 Jul 19
Utility
Method of Enhancing the Therapeutic Efficacy of Fexapotide Triflutate In Treating Luts
18 Nov 20
Disclosed are methods of enhancing the therapeutic efficacy of Fexapotide Triflutate (TF) in treating LUTS, both irritative and obstructive, that include administering a composition comprising FT at least twice over a period spanning more than one year.
Paul Averback
Filed: 12 May 19
Utility
Method of Treating Lower Urinary Tract Symptoms with Fexapotide Triflutate
18 Nov 20
Disclosed are methods of treating symptoms of Lower Urinary Tract Symptoms (LUTS), both obstructive and irritative, that include identifying patients having benign prostatic hyperplasia (BPH), and who also have LUTS, and administering a composition comprising FT to the so-identified patient.
Paul Averback
Filed: 12 May 19
Utility
Method of Improving Lower Urinary Tract Symptoms
18 Nov 20
The embodiments include methods of improving the symptoms of mammals having LUTS, using compositions containing Fexapotide Triflutate and a pharmaceutically acceptable carrier.
Paul Averback
Filed: 12 May 19
Utility
Method of Inducing Selective Prostate Glandular Pharmaco-ablation with Sparing of Nerves and Preservation of Sexual Function
26 Feb 20
Disclosed are methods of selective glandular pharmaco-ablation using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier.
Paul Averback
Filed: 22 Aug 18
Utility
Method of Treating Benign Prostatic Hyperlasia with Antibiotics
2 Oct 19
Disclosed are methods of improving the symptoms of mammals suffering from BPH using compositions containing one or more antibiotics.
Paul Averback
Filed: 27 Mar 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first